WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

Anil Kumar, Yash Srivastav, Vishal Laxman Waghamare, Foram Patel, Vishal Singh,
Konda V. V. S. Krishna, Harshita Srivastava, Geeta Rawat and Uriti Sri Venkatesh*

ABSTRACT

Birth control pills (BCPs), often known as oral contraceptive pills or OCPs, are becoming more and more popular across the world. Over 20% of people in 27 countries who are capable of becoming pregnant and are of reproductive age report using one of the 151 million OCP users that have been identified since 1994.OCPs can be prescribed for a number of conditions, such as menstruation problems, endometriosis, and polycystic ovarian syndrome, and they are often used to prevent unwanted pregnancies. Additionally, OCPs have been linked to a decreased risk of endometrial and ovarian cancer. However, the choice to take OCPs is unique and has to be carefully thought out, especially in light of evidence that some OCP user groups have increased rates of hypertension, cancer, cardiovascular disease (CVD), and venous thromboembolism (VTE). The modest amount of blood pressure (BP) elevation that can occur with OCP usage is unlikely to be clinically relevant, given the minimal absolute risk of CVD in otherwise healthy, reproductive-aged self-identifying women. However, OCP usage may raise a woman's risk to an intolerable degree if she has numerous significant risk factors.

[Full Text Article] [Download Certificate]